Automated Microbiology Market Size to Reach USD 9.38 Billion in 2028

The global automated microbiology market size is expected to reach USD 9.38 Billion in 2028 and register a CAGR of 8.9% over the forecast period, according to the latest report by Reports and Data. Major factors driving market revenue growth are increasing focus of error-free microbiological test results, rising adoption of automation technologies, growing need to minimize testing time, and major prevalence of infectious diseases globally. Automated microbiology is an advanced method used in microbiological research and development activities that delivers more efficient, accurate, and faster test results. This method automates critical processes such as isolation, detection, classification, and measurement of microorganisms in biological, ecological, and food sectors.

Automated microbiology applies different advanced diagnostic techniques such as DNA sequencing, DNA and RNA probe technology, immunoassays, monoclonal antibodies, and others. Monoclonal antibody is a laboratory-produced antibody created by cloning a white blood cell. These antibodies are usually used to treat various diseases such as cancer, asthma, septicemia, autoimmune diseases, poisoning, viral infections, substance abuse, and others. Monoclonal antibodies segment accounted for largest revenue share in the global market in 2020. This robust revenue share can be attributed to increasing use of monoclonal antibodies to generate clones of parent cells that are required to identify infected cells or diseases.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4185

The pharma and healthcare industry is expected to observe significant growth over the coming years attributed to the increasing incidence of chronic diseases across the globe, growing geriatric patient pool, availability of advanced and minimally invasive surgical and diagnostics procedures, favorable reimbursement scenario, and presence of a robust product pipeline of drugs and therapeutics. In addition, the growing integration of IoT, ML, and AI in medical procedures and equipment along with rapid progress in drug design and development. A combination of innovation and technology has brought about massive changes in the healthcare industry and the rapid adoption of telemedicine, remote consultation, and e-prescription has significantly contributed to the revenue growth of the market.

Some Key Highlights From the Report:

  • In January 2021, HiMedia Laboratories launched an automated RNA extraction protocol. This kit allows researchers to process 96 samples in 11 minutes.
  • Reagents segment accounted for largest revenue share in the global market in 2020. This can be attributed to rising demand for reagents and increasing costs of specialized kits.
  • North America is expected to continue to register significant revenue growth over the forecast period. Rapid developments and advancements in molecular diagnostics and adoption of advanced technologies are some major factors driving revenue growth of the market in the region.

  Research Methodology:

Reports and Data utilizes a unique approach to research to offer a comprehensive overview of the global Automated Microbiology Market to offer insights into investment opportunities for stakeholders, investors, clients, and businesses to make informed decisions. The report includes SWOT analysis, Porter’s Five Forces analysis, feasibility analysis, and investment return analysis to offer a better understanding of the market scenario.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/4185

Asia Pacific is expected to lead the market growth over the coming years owing to rapid advancements in the healthcare sector in APAC countries such as India, China, and Japan. North America is anticipated to register the highest market growth over the forecast period attributed to the increasing availability of robust healthcare and clinical settings, legalization of medical marijuana, favorable reimbursement scenario, presence of key market players, and rapid technological advancements in the region.

The growing popularity of over-the-counter medications driving market growth

Growing incidence of acute and chronic diseases and lesser access to advanced medical facilities owing to low disposable income levels are driving the demand for over-the-counter medications. Availability of generic and low-cost alternatives to medical therapies are some other factors playing a major role in driving demand for over-the-counter medications.

Restriction on product launches and R&D activities to hamper the market growth

The imposition of strict government regulations and shortage of funds has put a halt on product launches and R&D activities and is expected to restrain market growth over the forecast period. In addition, the launch of expensive drugs and therapies and increasing regulations regarding safety and approvals are also hampering the market growth.

  Competitive Landscape:

The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, mergers and acquisitions, collaborations, and joint ventures to gain a robust footing in the market.

Top Companies Profiled in the Report:

  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMeriux, Inc.
  • QIAGEN GmbH
  • Cepheid
  • Beckman Coulter
  • Agilent Technologies, Inc.
  • Gene-Probe, Inc.
  • Affymetrix, Inc.
  • Abbott Laboratories

  Automated Microbiology Market Segmentation:

Product Outlook:

  • Instruments
  • Automated Culture Systems
  • Microbiology Analyzers
  • Reagents

Diagnostic Technology Outlook:

  • DNA & RNA Probe Technology
  • DNA sequencing
  • Detection Techniques
  • Non-Isotopic Methods
  • Radioactive Methods
  • Immunoassays
  • Monoclonal Antibodies

End-use Outlook:

  • Clinical Laboratories
  • Biotechnology Industries
  • Others

Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)

  Frequently asked questions addressed in the report:

  • What is the revenue growth rate of the global Automated Microbiology market over the forecast period?
  • What are the major factors driving the growth of the Global Automated Microbiology Market?
  • What are the key challenges impacting the global Automated Microbiology market growth?
  • What are the outcomes of the SWOT Analysis and Porter’s Five Forces Analysis conducted in the report?

Request customization on the report @ https://www.reportsanddata.com/request-customization-form/4185

Thank you for reading our report. For more details please connect with us and our team will ensure the report is customized to meet all the needs of clients. The report also offers a comprehensive regional analysis and specific countries can be included in the report according to the requirements.

Explore Latest Trending Research Reports By Reports and Data:

Increase in Incidence of Cushing Syndrome Disease is Expected to Drive Cushing Syndrome Market @ https://www.biospace.com/article/increase-in-incidence-of-cushing-syndrome-disease-is-expected-to-drive-cushing-syndrome-market-growth/

North America Cluster Headache Market @ https://www.biospace.com/article/north-america-cluster-headache-market-is-expected-to-register-highest-revenue-share-during-the-forecast-period-2022-2030/

North America Chronic Obstructive Pulmonary Disease (COPD) Market @ https://www.biospace.com/article/north-america-chronic-obstructive-pulmonary-disease-copd-market-is-expected-to-register-highest-revenue-share-during-the-forecast-period-2022-2030/

Increase in Cancer Incidence        https://www.biospace.com/article/increase-in-cancer-incidence-and-key-players-investing-in-r-and-d-is-expected-to-drive-burkitt-lymphoma-market-growth-till-2030-reports-and-data/

  About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs